Related references
Note: Only part of the references are listed.Epigallocatechin-3-Gallate Plus Omega-3 Restores the Mitochondrial Complex I and F0F1-ATP Synthase Activities in PBMCs of Young Children with Down Syndrome: A Pilot Study of Safety and Efficacy
Iris Scala et al.
ANTIOXIDANTS (2021)
Effect of epigallocatechin gallate on the body composition and lipid profile of down syndrome individuals: Implications for clinical management
Laura Xicota et al.
CLINICAL NUTRITION (2020)
Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup® Dietary Supplement: Role of Green Tea Catechins
Yuchen Gu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Health comorbidities and cognitive abilities across the lifespan in Down syndrome
Carla M. Startin et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2020)
The Link between Homocysteine and Omega-3 Polyunsaturated Fatty Acid: Critical Appraisal and Future Directions
Gianluca Rizzo et al.
BIOMOLECULES (2020)
Bioavailability of Epigallocatechin Gallate Administered with Different Nutritional Strategies in Healthy Volunteers
Vicente Andreu Fernandez et al.
ANTIOXIDANTS (2020)
Subclinical Hypothyroidism in Children: When a Replacement Hormonal Treatment Might Be Advisable
Giuseppe Crisafulli et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Population nutrikinetics of green tea extract
Catharina Scholl et al.
PLOS ONE (2018)
Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits
Megan Stringer et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2017)
Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial
Rafael de la Torre et al.
LANCET NEUROLOGY (2016)
Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
Derliz Mereles et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
The Efficacy, Safety, and Tolerability of Donepezil for the Treatment of Young Adults With Down Syndrome'
Priya S. Kishnani et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
DYRK1A, a Novel Determinant of the Methionine-Homocysteine Cycle in Different Mouse Models Overexpressing this Down-Syndrome-Associated Kinase
Christophe Noll et al.
PLOS ONE (2009)
Inhibition of aromatase activity by green tea extract catechins and their endocrinological effects of oral administration in rats
K Satoh et al.
FOOD AND CHEMICAL TOXICOLOGY (2002)
Share Paper
